Showing results 3 to 3 of 3
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
A randomised study of lamivudine for prevention of HBV reactivation in HbsAg seropositive patients undergoing cytotoxic chemotherapy. Proceeding/Conference:Annual Meeting of the American Association for the Study of Liver Diseases, AASLD 2002 | 2002 |